Literature DB >> 21841848

Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.

Kyohei Higashi1, Mellisa Ly, Zhenyu Wang, Sayaka Masuko, Ujjwal Bhaskar, Eric Sterner, Fuming Zhang, Toshihiko Toida, Jonathan S Dordick, Robert J Linhardt.   

Abstract

Heparosan is a polysaccharide, which serves as the critical precursor in heparin biosynthesis and chemoenzymatic synthesis of bioengineered heparin. Because the molecular weight of microbial heparosan is considerably larger than heparin, the controlled depolymerization of microbial heparosan is necessary prior to its conversion to bioengineered heparin. We have previously reported that other acidic polysaccharides could be partially depolymerized with maintenance of their internal structure using a titanium dioxide-catalyzed photochemical reaction. This photolytic process is characterized by the generation of reactive oxygen species that oxidize individual saccharide residues within the polysaccharide chain. Using a similar approach, a microbial heparosan from Escherichia coli K5 of molecular weight >15,000 was depolymerized to a heparosan of molecular weight 8,000. The (1)H-NMR spectra obtained showed that the photolyzed heparosan maintained the same structure as the starting heparosan. The polysaccharide chains of the photochemically depolymerized heparosan were also characterized by electrospray ionization-Fourier-transform mass spectrometry. While the chain of K5 heparosan starting material contained primarily an even number of saccharide residues, as a result of coliphage K5 lyase processing, both odd and even chain numbers were detected in the photochemically-depolymerized heparosan. These results suggest that the photochemical depolymerization of heparosan was a random process that can take place at either the glucuronic acid or the N-acetylglucosamine residue within the heparosan polysaccharide.

Entities:  

Year:  2011        PMID: 21841848      PMCID: PMC3153860          DOI: 10.1016/j.carbpol.2011.06.042

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  20 in total

1.  High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis.

Authors:  Tatiana N Laremore; Mellisa Ly; Kemal Solakyildirim; Dmitri V Zagorevski; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-03-06       Impact factor: 3.365

2.  Analysis of E. coli K5 capsular polysaccharide heparosan.

Authors:  Mellisa Ly; Zhenyu Wang; Tatiana N Laremore; Fuming Zhang; Weihong Zhong; Dennis Pu; Dmitri V Zagorevski; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-04-21       Impact factor: 4.142

3.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

Review 4.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

5.  Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

Authors:  Zhenqing Zhang; Boyangzi Li; Jiraporn Suwan; Fuming Zhang; Zhenyu Wang; Haiying Liu; Barbara Mulloy; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

6.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin.

Authors:  W F Vann; M A Schmidt; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1981-05-15

7.  Orthogonal analytical approaches to detect potential contaminants in heparin.

Authors:  Marco Guerrini; Zhenqing Zhang; Zachary Shriver; Annamaria Naggi; Sayaka Masuko; Robert Langer; Benito Casu; Robert J Linhardt; Giangiacomo Torri; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

8.  Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides.

Authors:  Charuwan Thanawiroon; Kevin G Rice; Toshihiko Toida; Robert J Linhardt
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

Review 9.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

10.  Analysis of glycosaminoglycans with polysaccharide lyases.

Authors:  R J Linhardt
Journal:  Curr Protoc Mol Biol       Date:  2001-05
View more
  7 in total

1.  Combinatorial one-pot chemoenzymatic synthesis of heparin.

Authors:  Ujjwal Bhaskar; Guoyun Li; Li Fu; Akihiro Onishi; Mathew Suflita; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2014-11-07       Impact factor: 9.381

2.  Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Authors:  Kyohei Higashi; Saori Hosoyama; Asami Ohno; Sayaka Masuko; Bo Yang; Eric Sterner; Zhenyu Wang; Robert J Linhardt; Toshihiko Toida
Journal:  Carbohydr Polym       Date:  2012-02-01       Impact factor: 9.381

3.  Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes.

Authors:  Julie M Beaudet; Leandra Mansur; Eun Ji Joo; Eyal Kamhi; Bo Yang; Thomas M Clausen; Ali Salanti; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2013-10-25       Impact factor: 2.916

4.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

Review 5.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

Review 6.  Engineered heparins as new anticoagulant drugs.

Authors:  Deepika Vaidyanathan; Asher Williams; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Bioeng Transl Med       Date:  2016-11-21

Review 7.  Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.

Authors:  Masayuki Ishihara; Shingo Nakamura; Yoko Sato; Tomohiro Takayama; Koichi Fukuda; Masanori Fujita; Kaoru Murakami; Hidetaka Yokoe
Journal:  Molecules       Date:  2019-12-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.